Genetics of Glucose regulation in Gestation and Growth (Gen3G): A prospective prebirth cohort of mother-child pairs in Sherbrooke, Canada

BMJ Open

Volumn 6, Issue 2, 2016, Pages

  Guillemette, Laetitia ^a   Allard, Catherine ^b   Lacroix, Marilyn ^a   Patenaude, Julie ^a   Battista, Marie Claude ^a   Doyon, Myriam ^c   Moreau, Julie ^c   Ménard, Julie ^c   Bouchard, Luigi ^a,c,d   Ardilouze, Jean Luc ^a,c   Perron, Patrice ^a,c   Hivert, Marie France ^a,c,e,f  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^d CHICOUTIMI HOSPITAL   (Canada)

^e HARVARD MEDICAL SCHOOL   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; DNA; GLUCOSE; VITAMIN D; 25-HYDROXYVITAMIN D; GLUCOSE BLOOD LEVEL; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE; BLOOD SAMPLING; COHORT ANALYSIS; DELIVERY; DNA EXTRACTION; FEMALE; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; GENETIC REGULATION; GENOTYPE ENVIRONMENT INTERACTION; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; LIFESTYLE; MACROSOMIA; MAJOR CLINICAL STUDY; METABOLIC REGULATION; MOTHER; ORAL GLUCOSE TOLERANCE TEST; PLACENTA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; SECOND TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD; ANALOGS AND DERIVATIVES; BODY COMPOSITION; BODY MASS; CANADA; DIABETES, GESTATIONAL; FETUS BLOOD; GENETIC EPIGENESIS; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; MALE; METABOLISM; NEWBORN; OBESITY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDY; RISK FACTOR; VITAMIN D DEFICIENCY; YOUNG ADULT;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; CANADA; DIABETES, GESTATIONAL; EPIGENESIS, GENETIC; FEMALE; FETAL BLOOD; GLUCOSE TOLERANCE TEST; HUMANS; INFANT, NEWBORN; INSULIN RESISTANCE; MALE; OBESITY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84960446239     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-010031     Document Type: Article

References (32)

1. Brownell KD, Yach D, Stuckler D. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 2006;12:62-6.
2. De Lorenzo A, Bianchi A, Maroni P, et al. Adiposity rather than BMI determines metabolic risk. Int J Cardiol 2013;166:111.
3. Neeland IJ, Turer AT, Ayers CR, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012;308:1150-9.
4. Feig DS, Zinman B, Wang X, et al. Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 2008;179:229-34.
5. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862-8.
6. Huang RC, De Klerk NH, Smith A, et al. Lifecourse childhood adiposity trajectories associated with adolescent insulin resistance. Diabetes Care 2011;34:1019-25.
7. Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339-48.
8. Boney CM, Verma A, Tucker R, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005;115:e290-6.
9. Hivert MF, Allard C, Menard J, et al. Impact of the creation of a specialized clinic for prenatal blood sampling and follow-up care in pregnant women. J Obstet Gynaecol Can 2012;34:236-42.
10. Canadian Diabetes A. Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. 2008;32(Supp 1):S171-2.
11. Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-82.
12. Nunez C, Gallagher D, Visser M, et al. Bioimpedance analysis: evaluation of leg-to-leg system based on pressure contact footpad electrodes. Med Sci Sports Exerc 1997;29:524-31.
13. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Abridged edn. Champaign, IL: Human Kinetics Books, 1991.
14. Schmelzle HR, Fusch C. Body fat in neonates and young infants: validation of skinfold thickness versus dual-energy X-ray absorptiometry. Am J Clin Nutr 2002;76:1096-100.
15. Statistics Canada HC. Enquête sur la sante dans les collectivites canadiennes. Cycle 2.2. Nutrition (2004): securite alimentaire liee au revenu dans les menages canadiens. Ottawa, ON: Bureau de la politique et de la promotion de la nutrition, Sante Canada, 2007.
16. Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 2013;13:59.
17. Gagnon C, Baillargeon JP, Desmarais G, et al. Prevalence and predictors of vitamin D insufficiency in women of reproductive age living in northern latitude. Eur J Endocrinol 2010;163:819-24.
18. Aronov PA, Hall LM, Dettmer K, et al. Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2008;391:1917-30.
19. Kirwan JP, Huston-Presley L, Kalhan SC, et al. Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 2001;24:1602-7.
20. McIntyre HD, Chang AM, Callaway LK, et al. Hormonal and metabolic factors associated with variations in insulin sensitivity in human pregnancy. Diabetes Care 2010;33:356-60.
21. Matsuda M, De Fronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-70.
22. Lacroix M, Battista MC, Doyon M, et al. Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus. Diabetes Care 2013;36:1577-83.
23. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002;51:2207-13.
24. Jahromi AS, Zareian P, Madani A. Association of insulin resistance with serum interleukin-6 and TNF-alpha levels during normal pregnancy. Biomark Insights 2011;6:1-6.
25. McLachlan KA, O'Neal D, Jenkins A, et al. Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Res Rev 2006;22:131-8.
26. Guillemette L, Lacroix M, Battista MC, et al. TNFα dynamics during the oral glucose tolerance test vary according to the level of insulin resistance in pregnant women. J Clin Endocrinol Metab 2014;99:1862-9.
27. Lacroix M, Battista MC, Doyon M, et al. Lower vitamin D levels at first trimester are associated with higher risk of developing gestational diabetes mellitus. Acta Diabetol 2014;51:609-16.
28. Liu L, Feng R, Guo F, et al. Targeted metabolomic analysis reveals the association between the postprandial change in palmitic acid, branched-chain amino acids and insulin resistance in young obese subjects. Diabetes Res Clin Pract 2015;108:84-93.
29. Padberg I, Peter E, Gonzalez-Maldonado S, et al. A new metabolomic signature in type-2 diabetes mellitus and its pathophysiology. PLoS ONE 2014;9:e85082.
30. Ho JE, Larson MG, Vasan RS, et al. Metabolite profiles during oral glucose challenge. Diabetes 2013;62:2689-98.
31. Grant CC, Stewart AW, Scragg R, et al. Vitamin D during pregnancy and infancy and infant serum 25-hydroxyvitamin D concentration. Pediatrics 2014;133:e143.
32. Lagiou P, Hsieh C-C, Samoli E, et al. Associations of placental weight with maternal and cord blood hormones. Ann Epidemiol 2013;23:669-73.